Literature DB >> 21087756

A comparison of the conformability of everolimus-eluting bioresorbable vascular scaffolds to metal platform coronary stents.

Josep Gomez-Lara1, Hector M Garcia-Garcia, Yoshinobu Onuma, Scot Garg, Evelyn Regar, Bernard De Bruyne, Stefan Windecker, Dougal McClean, Leif Thuesen, Dariusz Dudek, Jacques Koolen, Robert Whitbourn, Pieter C Smits, Bernard Chevalier, Cécile Dorange, Susan Veldhof, Marie-Angèle Morel, Ton de Vries, John A Ormiston, Patrick W Serruys.   

Abstract

OBJECTIVES: The aim of this study was to assess the differences in terms of curvature and angulation of the treated vessel after the deployment of either a metallic stent or a polymeric scaffold device.
BACKGROUND: Conformability of metallic platform stents (MPS) is the major determinant of geometric changes in coronary arteries caused by the stent deployment. It is not known how bioresorbable polymeric devices perform in this setting.
METHODS: This retrospective study compares 102 patients who received an MPS (Multi-link Vision or Xience V, Abbott Vascular, Santa Clara, California) in the SPIRIT FIRST and II trials with 89 patients treated with the Revision 1.1 everolimus-eluting bioresorbable vascular scaffold (BVS) (Abbott Vascular, Santa Clara, California) from cohort B of the ABSORB (A bioabsorbable everolimus-eluting coronary stent system) trial. All patients were treated with a single 3 × 18 mm device. Curvature and angulation were measured with dedicated software by angiography.
RESULTS: Both the MPS and BVS groups had significant changes in relative region curvature (MPS vs. BVS: 28.7% vs. 7.5%) and angulation (MPS vs. BVS: 25.4% vs. 13.4%) after deployment. The unadjusted comparisons between the 2 groups showed for BVS a nonsignificant trend for less change in region curvature after deployment (MPS vs. BVS: 0.085 cm(-1) vs. 0.056 cm(-1), p = 0.06) and a significantly lower modification of angulation (MPS vs. BVS 6.4° vs. 4.3°, p = 0.03). By multivariate regression analysis, the independent predictors of changes in curvature and angulation were the pre-treatment region curvature, the pre-treatment region angulation, and the used device.
CONCLUSIONS: Bioresorbable vascular scaffolds have better conformability than conventional MPS. The clinical significance of the observed differences will require further investigation.
Copyright © 2010 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21087756     DOI: 10.1016/j.jcin.2010.07.016

Source DB:  PubMed          Journal:  JACC Cardiovasc Interv        ISSN: 1936-8798            Impact factor:   11.195


  22 in total

Review 1.  Restenosis after PCI. Part 2: prevention and therapy.

Authors:  J Wouter Jukema; Tarek A N Ahmed; Jeffrey J W Verschuren; Paul H A Quax
Journal:  Nat Rev Cardiol       Date:  2011-10-11       Impact factor: 32.419

2.  Crimping-induced structural gradients explain the lasting strength of poly l-lactide bioresorbable vascular scaffolds during hydrolysis.

Authors:  Karthik Ramachandran; Tiziana Di Luccio; Artemis Ailianou; Mary Beth Kossuth; James P Oberhauser; Julia A Kornfield
Journal:  Proc Natl Acad Sci U S A       Date:  2018-09-17       Impact factor: 11.205

3.  Bioresorbable Scaffolds in Spontaneous Coronary Artery Dissection: Long-Term Follow-Up in 4 Patients.

Authors:  Santiago Jesús Camacho Freire; Antonio Enrique Gómez Menchero; Jessica Roa Garrido; Javier León Jiménez; Rosa Cardenal Piris; José Francisco Díaz Fernández
Journal:  Tex Heart Inst J       Date:  2017-12-19

Review 4.  Bioresorbable vascular scaffolds - basic concepts and clinical outcome.

Authors:  Ciro Indolfi; Salvatore De Rosa; Antonio Colombo
Journal:  Nat Rev Cardiol       Date:  2016-09-29       Impact factor: 32.419

Review 5.  Methods to assess bioresorbable vascular scaffold devices behaviour after implantation.

Authors:  Alberto Pernigotti; Elisabetta Moscarella; Giosafat Spitaleri; Claudia Scardino; Kohki Ishida; Salvatore Brugaletta
Journal:  J Thorac Dis       Date:  2017-08       Impact factor: 2.895

6.  The Bioresorbable Stent in Perspective-How Much of an Advance is It?

Authors:  Viktor Kočka; Petr Widimský
Journal:  Interv Cardiol       Date:  2014-03

Review 7.  Drug-eluting coronary stents: insights from preclinical and pathology studies.

Authors:  Sho Torii; Hiroyuki Jinnouchi; Atsushi Sakamoto; Matthew Kutyna; Anne Cornelissen; Salome Kuntz; Liang Guo; Hiroyoshi Mori; Emanuel Harari; Ka Hyun Paek; Raquel Fernandez; Diljon Chahal; Maria E Romero; Frank D Kolodgie; Anuj Gupta; Renu Virmani; Aloke V Finn
Journal:  Nat Rev Cardiol       Date:  2019-07-25       Impact factor: 32.419

8.  Tungsten disulfide nanotubes enhance flow-induced crystallization and radio-opacity of polylactide without adversely affecting in vitro toxicity.

Authors:  Karthik Ramachandran; Zixuan Shao; Tiziana Di Luccio; Bo Shen; Edgar E Ruiz Bello; Loredana Tammaro; Fulvia Villani; Fausta Loffredo; Carmela Borriello; Francesca Di Benedetto; Eimear Magee; Tony McNally; Julia A Kornfield
Journal:  Acta Biomater       Date:  2021-11-17       Impact factor: 10.633

9.  Bio-Adaption between Magnesium Alloy Stent and the Blood Vessel: A Review.

Authors:  Jun Ma; Nan Zhao; Lexxus Betts; Donghui Zhu
Journal:  J Mater Sci Technol       Date:  2015-12-24       Impact factor: 8.067

Review 10.  Absorbable stent: focus on clinical applications and benefits.

Authors:  Nieves Gonzalo; Carlos Macaya
Journal:  Vasc Health Risk Manag       Date:  2012-02-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.